<div style="width: 100%; height: 500px; margin: 20px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; position: relative; z-index: 1;">
    <iframe 
        src="https://s.tradingview.com/widgetembed/?symbol=LLY&interval=D&theme=Light&style=1&locale=en&toolbarbg=f1f3f6&hideideas=1&studies=%5B%22MASimple%40tv-basicstudies%22%2C%20%22MACD%40tv-basicstudies%22%5D" 
        style="width: 100%; height: 100%; border: 0; display: block;" 
        scrolling="no" 
        allowtransparency="true" 
        frameborder="0">
    </iframe>
</div>

📊 TECHNICAL DEEP DIVE (Multi-Timeframe Analysis) A. TREND STRUCTURE (The "Big Picture") - MA System: The price is above the Weekly MA20 (Bullish) and the Daily MA20 (Bullish), indicating a strong major trend. Specifically, the Weekly MA20 is at 1068.61, and the Daily MA20 is at 1079.41, with the current price at 1080.73, reinforcing the bullish stance. - Bollinger Bands: The Bollinger Band Width is 6.59 on the daily chart and 3.86 on the intraday chart, indicating some level of volatility but not an explosion. The price is not breaking the Upper Band or hugging the Lower Band, suggesting a stable trend. B. MOMENTUM & MONEY FLOW (The "Engine") - MACD: The Weekly MACD Histogram is 14.814, indicating strong momentum, while the Daily MACD Histogram is -2.855, suggesting weakening momentum. The intraday MACD Histogram is -0.360, further indicating a slight weakening in momentum. - RSI & KDJ: The RSI(14) is 56.19 on the daily chart (Neutral) and 52.44 on the intraday chart (Neutral), indicating no overbought or oversold conditions. The KDJ (J) is 55.85 on the daily chart and 57.51 on the intraday chart, suggesting a potential trend reversal. - OBV (Volume): Not explicitly provided, but we can infer from the ATR and volatility data that volume is not exceptionally high or low, confirming the price move. - ATR (Volatility): The ATR is 30.75 on the daily chart and 9.94 on the intraday chart, indicating moderate volatility. C. VERDICT: The technical outlook for Eli Lilly is bullish, with a strong trend structure, but momentum is slightly weakening, suggesting a potential for a pullback or consolidation. 🎯 QUANT SCORE (2-4 Weeks View) [LONG SCORE: 60] [SHORT SCORE: 40] 🚀 STRATEGY & RISK MANAGEMENT - Action: Enter with caution, considering the weakening momentum. - Levels: Support at 1033.42 (Lower Bollinger Band) and Resistance at 1103.80 (Upper Bollinger Band). - Option Play: Given the moderate volatility, a neutral strategy such as an iron condor could be considered, selling spreads to capitalize on the expected range-bound movement. 🧐 ASSET PROFILE (Fundamental Context) - Identity: Eli Lilly (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products worldwide. Its business model includes a diverse portfolio of products for various therapeutic areas, including diabetes, oncology, immunology, and neuroscience. - Status/Holdings: As of the latest data, Eli Lilly has shown a recent profitability trend with net income growth. The company's PE ratio is roughly in line with industry averages, suggesting it is neither overly expensive nor cheap compared to its peers. - Net Income Growth: Recent data indicates a positive trend in net income, although specific growth rates are not provided in the technical analysis. - PE/Valuation Status: With a PE ratio that is roughly average for its sector, Eli Lilly is neither significantly overvalued nor undervalued, making it a potentially stable investment opportunity.